Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 548

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization

Nikolovska-Coleska, Zaneta, Wang, Renxiao, Fang, Xueliang, Pan, Hongguang, Tomita, York, Li, Peng, Roller, Peter P., Krajewski, Krzysztof, Saito, Naoyuki G., Stuckey, Jeanne A., Wang, Shaomeng·2004·Analytical Biochemistry
DOI 10.1016/j.ab.2004.05.055
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ab.2004.05.055

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 37

  1. Reed, 2002, Apoptosis-based therapies, Nature Rev. Drug Discov., 1, 111, 10.1038/nrd726 · DOI · Paper page
  2. Deveraux, 1999, IAP family proteins—suppressors of apoptosis, Genes Dev., 13, 239, 10.1101/gad.13.3.239 · DOI · Paper page
  3. LaCasse, 1998, The inhibitors of apoptosis (IAPs) and their emerging role in cancer, Oncogene, 17, 3247, 10.1038/sj.onc.1202569 · DOI · Paper page
  4. Fesik, 2000, Insights into programmed cell death through structural biology, Cell, 103, 273, 10.1016/S0092-8674(00)00119-7 · DOI · Paper page
  5. Takahashi, 1998, A single BIR domain of XIAP sufficient for inhibiting caspases, J. Biol. Chem., 273, 7787, 10.1074/jbc.273.14.7787 · DOI · Paper page
  6. Riedl, 2001, Structural basis for the inhibition of caspase-3 by XIAP, Cell, 104, 791, 10.1016/S0092-8674(01)00274-4 · DOI · Paper page
  7. Chai, 2001, Structural basis of caspase-7 inhibition by XIAP, Cell, 104, 769, 10.1016/S0092-8674(01)00272-0 · DOI · Paper page
  8. Huang, 2001, Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain, Cell, 104, 781
  9. Deveraux, 1999, Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases, EMBO J., 18, 5242, 10.1093/emboj/18.19.5242 · DOI · Paper page
  10. Srinivasula, 2001, A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis, Nature, 410, 112, 10.1038/35065125 · DOI · Paper page
  11. Sun, 2000, NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP, J. Biol. Chem., 275, 33777, 10.1074/jbc.M006226200 · DOI · Paper page
  12. Chai, 2000, Structural and biochemical basis of apoptotic activation by Smac/DIABLO, Nature, 406, 855, 10.1038/35022514 · DOI · Paper page
  13. Liu, 2000, Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain, Nature, 408, 1004, 10.1038/35050006 · DOI · Paper page
  14. Srinivasula, 2000, Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway, J. Biol. Chem., 275, 36152, 10.1074/jbc.C000533200 · DOI · Paper page
  15. Wu, 2000, Structural basis of IAP recognition by Smac/DIABLO, Nature, 408, 1008, 10.1038/35050012 · DOI · Paper page
  16. Wu, 2001, Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides, Mol. Cell, 8, 95, 10.1016/S1097-2765(01)00282-9 · DOI
  17. Ambrosini, 1997, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nature Med., 3, 917, 10.1038/nm0897-917 · DOI · Paper page
  18. Vucic, 2000, ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas, Curr. Biol., 10, 1359, 10.1016/S0960-9822(00)00781-8 · DOI · Paper page
  19. Tamm, 2000, Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias, Clin. Cancer Res., 6, 1796
  20. Holcik, 2000, Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death, Oncogene, 19, 4174, 10.1038/sj.onc.1203765 · DOI · Paper page
  21. Sasaki, 2000, Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells, Cancer Res., 60, 5659
  22. Ng, 2002, Mol. Cancer Ther., 1, 1051
  23. Hu, 2003, Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo, Clin. Cancer Res., 9, 2826
  24. Wu, 2003, Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction, Chem. Biol., 10, 759, 10.1016/S1074-5521(03)00157-1 · DOI
  25. Glover, 2003, A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay, Anal. Biochem., 320, 157, 10.1016/S0003-2697(03)00389-0 · DOI
  26. Nikolovska-Coleska, 2004, Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of traditional herbal medicine three-dimensional structural database, J. Med. Chem., 47, 2430, 10.1021/jm030420+ · DOI · Paper page
  27. Wu, 1997, A high-throughput STAT binding assay using fluorescence polarization, Anal. Biochem., 249, 29, 10.1006/abio.1997.2158 · DOI
  28. Pin, 1999, Analysis of protein-peptide interaction by a miniaturized fluorescence polarization assay using cyclin-dependent kinase 2/cyclin E as a model system, Anal. Biochem., 275, 156, 10.1006/abio.1999.4331 · DOI
  29. Bolger, 1998, Rapid screening of environmental chemicals for estrogen receptor binding capacity, Environ. Health Perspect., 106, 551, 10.1289/ehp.98106551 · DOI · Paper page
  30. Owicki, 2000, Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer, J. Biomol. Screen., 5, 297, 10.1177/108705710000500501 · DOI · Paper page
  31. Pope, 1999, Homogeneous fluorescence readouts for miniaturized high-throughput screening: theory and practice, Drug Discov. Today, 4, 350, 10.1016/S1359-6446(99)01340-9 · DOI
  32. Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J. Biomol. Screen., 4, 67, 10.1177/108705719900400206 · DOI · Paper page
  33. Kipp, 2002, Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners, Biochemistry, 41, 7344, 10.1021/bi0121454 · DOI
  34. Huang, 2003, Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand, J. Biomol. Screen., 8, 34, 10.1177/1087057102239666 · DOI
  35. PanVera Fluorescence Polarization Technical Resource Guide, Panvera Corporation, Madison, WI, 2002, pp.3–13
  36. Turek-Etienne, 2003, Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphatase, J. Biomol. Screen., 8, 176, 10.1177/1087057103252304 · DOI
  37. Munson, 1988, An exact correction to the “Cheng–Prusoff” correction, J. Recept. Res., 8, 533, 10.3109/10799898809049010 · DOI

Cited by

Metadata

Authors
Nikolovska-Coleska, Z., Wang, R., Fang, X., Pan, H., Tomita, Y., Li, P., Roller, P. P., Krajewski, K., Saito, N. G., Stuckey, J. A., & Wang, S.
Venue
Analytical Biochemistry
Publisher
Elsevier BV
Published
2004-09
Volume
332
Issue
2
Pages
261-273
ISSN
0003-2697 (ISSN-L)
DOI
10.1016/j.ab.2004.05.055
OpenAlex
W2095453782
Cited by
548
References
2
FWCI
2.51
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.